Clinical investigations of Toll-like receptor agonists

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Reply to topic
Clinical investigations of Toll-like receptor agonists
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Reply with quote


Expert Opinion on Investigational Drugs , July 2008, Vol. 17, No. 7, Pages 1051-1065.
<br/>
Background: Toll-like receptors (TLR) represent a family of surface molecules that function as primary sensors of the innate immune system to recognize microbial pathogens. Ligand binding to TLR results in activation of cellular signaling pathways that ...

Read more...

Source: Expert Opinion: Expert Opinion on Investigational Drugs: Table of Contents
Table of Contents for Expert Opinion on Investigational Drugs. List of articles from both the latest and ahead of print issues.
View user's profileSend private message
Clinical investigations of Toll-like receptor agonists
All times are GMT - 7 Hours  
Page 1 of 1  

  
  
 Reply to topic  
Forum Map
Site Map